Impact of Diagnosed and Undiagnosed Respiratory Pseudomonas on VAP and VAE During Long Term Acute Care
Background: Clinically diagnosed ventilator associated pneumonia (VAP) is common in the long term acute care hospital (LTACH) setting and may contribute to adverse ventilator associated events (VAEs) Pseudomonas aeruginosa is a common causative organism of VAP. We evaluated the impact of respiratory P. aeruginosa colonization and bacterial community dominance, both diagnosed and undiagnosed, on subsequent P. aeruginosa VAP and VAE events during long term acute care. Methods: We enrolled 83 patients on LTACH admission for ventilator weaning, performed longitudinal sampling of endotracheal aspirates followed by 16S rRNA gene sequencing (Illumina HiSeq) and bacterial community profiling (QIIME2) Statistical analysis was performed with R and Stan; mixed effects models were fit to relate the abundance of respiratory Psa on admission to clinically diagnosed VAP and VAE events. Results: Of the 83 patients included, 12 were diagnosed with P. aeruginosa pneumonia during the 14 days prior to LTACH admission (known P. aeruginosa) and 22 additional patients received anti P. aeruginosa antibiotics within 48 hours of admission (suspected P. aeruginosa) 49 patients had no known or suspected P. aeruginosa (unknown P. aeruginosa) Among the known P. aeruginosa group, all 12 patients had P. aeruginosa detectable by 16S sequencing, with elevated admission P. aeruginosa proportional abundance (median, 0.97; IQR, 0.33 1) Among the suspected P. aeruginosa group, all 22 patients had P. aeruginosa detectable by 16S sequencing, with a wide range of admission P. aeruginosa proportional abundance (median, 0.0088; IQR, 0.00012 0.31) Of the 49 patients in the unknown group, 47 also had detectable respiratory Psa, and many had high P. aeruginosa proportional abundance at admission (median, 0.014; IQR, 0.00025 0.52) Incident P. aeruginosa VAP was observed within 30 days in 4 of the known P. aeruginosa patients (33.3% 5 of the suspected P. aeruginosa patients (22.7% and 8 of the unknown P. aeruginosa patients (16.3% VAE was observed within 30 days in 1 of the known P. aeruginosa patients (8.3% 2 of the suspected P. aeruginosa patients (9.1% and 1 of the unknown P. aeruginosa patients (2% Admission P. aeruginosa abundance was positively associated with VAP and VAE risk in all groups, but the association only achieved statistical significance in the unknown group (type S error <0.002 for 30 day VAP and <0.011 for 30 day VAE) Conclusions: We identified a high prevalence of unrecognized respiratory P. aeruginosa colonization among patients admitted to LTACH for weaning from mechanical ventilation. The admission P. aeruginosa proportional abundance was strongly associated with increased risk of incident P. aeruginosa VAP among these patients. Funding: None Disclosures: None
Infection Control Hospital Epidemiology